A carregar...
Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches
Cancer immunotherapy has evolved dramatically with improved understanding of immune microenvironment and immunosurveillance. The immunogenicity of breast cancer is rather heterogeneous. Specific subtypes of breast cancer such as estrogen receptor (ER)-negative, human EGF receptor 2 (HER2)-positive,...
Na minha lista:
| Publicado no: | Breast Cancer (Dove Med Press) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6340364/ https://ncbi.nlm.nih.gov/pubmed/30697064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S175360 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|